Andrew F. Teich, MD, PhD

Academic Appointments

  • Assistant Professor of Pathology and Cell Biology (in Neurology)

Current Administrative Positions

  • Director of the New York Brain Bank
Andrew F. Teich, MD, PhD

Email: aft25@cumc.columbia.edu

Our laboratory uses human brain tissue specimens and human cell-derived model systems to study the pathogenesis of Alzheimer’s disease (AD) and identify viable therapeutic targets.  I am also the Director of the New York Brain Bank, and we are using tissue specimens from this repository to better understand the heterogeneity of AD pathology and how this may impact clinical presentation.  We use a broad range of computational and molecular techniques, and collaborate extensively with other PIs at CUIMC.

Departments and Divisions

  • Department of Pathology & Cell Biology
    Division of Anatomic Pathology
  • Department of Neurology

Board Certifications

  • Anatomic Pathology
  • Neuropathology

Areas of Expertise

  • Pathology - Anatomic

Education and Training

  • Columbia University College of Physicians and Surgeons
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Residency: 2008 NewYork-Presbyterian/Columbia University Medical C
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Locations

  • CUIMC/Presbyterian Hospital and Vanderbilt Clinic

    622 West 168th Street
    New York, NY 10032

Centers / Institutes / Programs

  • Taub Institute for Research on Alzheimer's Disease and the Aging Brain

Provider Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Insurance Programs

Please contact the provider's office directly to verify that your particular insurance is accepted.

  • AETNA [Aetna Signature Administrators, EPO, HMO, Medicare Managed Care, NYP Employee Plan, NY Signature, POS, PPO, Student Health]
  • CIGNA [EPO, Great West (National), HMO, POS, PPO]
  • Emblem/GHI [Medicare Managed Care, PPO]
  • Emblem/HIP [ConnectiCare, EPO, Essential Plan, HMO, Medicaid Managed Care, Medicare Managed Care, POS, PPO, Select Care (Exchange), Vytra]
  • Empire Blue Cross/Blue Shield [EPO, HMO, PPO]
  • Local 1199 [Local 1199]
  • MagnaCare (National) [MagnaCare]
  • Medicare [Railroad, Traditional Medicare]
  • Multiplan [Multiplan]
  • Oxford Health Plans [Freedom, Liberty]
  • RiverSpring [Special Needs]
  • UnitedHealthcare [Columbia University Employee Plan, Compass (Exchange), Empire Plan, HMO, Medicare Managed Care, POS, PPO]

This provider accepts new patients

Lab Locations

  • CUIMC/Presbyterian Hospital and Vanderbilt Clinic

    622 West 168th Street
    New York, NY 10032

Honors and Awards

2016 Paul B. Beeson Emerging Leaders Career Development Award in Aging, NIH-NIA

2014 Margaret M. Cahn Research Award, Alzheimer’s Association

2011 Louis V. Gerstner, Jr. Scholar Award, Louis V. Gerstner, Jr. Scholar Foundation/Columbia University

NIH Grants

  • ALZHEIMER S DISEASE RESEARCH CENTER (Federal Gov)

    Jun 1 2020 - Apr 30 2025

    ACCELERATED NON-ATHEROSCLEROTIC BRAIN ARTERIAL AGING RELATIONSHIP TO ALZHEIMER S DISEASE (Federal Gov)

    Sep 15 2019 - May 31 2024

    A TRANSLATIONAL BIOINFORMATICS APPROACH TO RESCUING SYNAPTIC AND NEUROPHYSIOLOGIC DYSFUNCTION IN ALZHEIMER S DISEASE (Federal Gov)

    Sep 15 2018 - May 31 2023

    ALZHEIMER S DISEASE RESEARCH CENTER - OVERALL (Federal Gov)

    Jun 15 2015 - May 31 2021

    ALZHEIMER S DISEASE RESEARCH CENTER - OVERALL (Federal Gov)

    Jun 15 2015 - May 31 2021

    UCD A20-0610-S002 THE NEUROPATHOLOGIC LANDSCAPE OF ALZHEIMER S DISEASE HISPANIC DECEDENTS (Federal Gov)

    Aug 1 2019 - Apr 30 2021

    ALZHEIMER S DISEASE RESEARCH CENTER - OVERALL (Federal Gov)

    Jun 15 2015 - May 31 2020

    ASYSTEMS APPROACH TO DNA METHYLATION, GENE EXPRESSION, AND COGNITIVE DYSFUNCTION IN ALZHEIMER S DISEASE (Federal Gov)

    May 1 2015 - Jan 31 2020

    A SYSTEMS APPROACH TO DNA METHYLATION, GENE EXPRESSION, AND COGNITIVE DYSFUNCTION IN ALZHEIMER S DISEASE (Federal Gov)

    May 1 2015 - Jan 31 2020

    A SYSTEMS APPROACH TO DNA METHYLATION, GENE EXPRESSION, AND COGNITIVE DYSFUNCTION IN ALZHEIMER S DISEASE (Federal Gov)

    May 1 2015 - Jan 31 2020

    REGULATION OF RETROMER PROTEINS THROUGH AN ALZHEIMER S DISEASE SPECIFIC TRANSCRIPTION FACTOR COMPLEX (Federal Gov)

    Sep 30 2018 - Aug 31 2019

    NATIONAL MULTIPLE SCLEROSIS TISSUE REPOSITORY NETWORK (Private)

    Jan 1 2019 - Jun 30 2019

    ANINTEGRATIVE ANALYSIS OF DNA METHYLATION, TRANSCRIPTOMIC CHANGES, AND COGNITIVE DYSFUNCTION IN ALZHEIMER S DISEASE (Federal Gov)

    Sep 30 2016 - May 31 2019

    A CROSS-SPECIES STUDY OF DNA METHYLATION IN ALZHEIMER S DISEASE DEMENTIA (Private)

    Jun 1 2016 - May 31 2018

    A STUDY OF ZCCHC17 REGULATION OF SYNAPTIC GENES IN ALZHEIMERS DISEASE (Federal Gov)

    Sep 1 2014 - May 31 2017

    A THERAPEUTIC APPROACH TO SYNAPTIC DYSFUNCTION IN ALZHEIMER S DISEASE (Private)

    Jan 1 2014 - Dec 31 2015

    ALZHEIMER S DISEASE RESEARCH CENTER AT COLUMBIA UNIVERSITY (Federal Gov)

    Jun 1 2010 - May 31 2015

    ALZHEIMER S DISEASE RESEARCH CENTER AT COLUMBIA UNIVERSITY (Federal Gov)

    Jun 1 2010 - May 31 2015

    BETA-AMYLOID42 POSITIVELY REGULATES ALPHA7-CHOLINERGIC RECEPTORS (Private)

    Sep 1 2011 - Aug 31 2013

Publications

  1. Huang, W., A.M. Bartosch, H. Xiao, X. Flowers, S. Leskinen, Z. Tomljanovic, G. Iodice, D. Boyett, E. Spinazzi, V. Menon, R.A. McGovern, G.M. McKhann, and A.F. Teich, An Immune Response characterizes early Alzheimer’s disease pathology and subjective cognitive impairment in hydrocephalus biopsies. Nature Communications, 2021 Sep 27;12(1):5659. doi: 10.1038/s41467-021-25902-y.
  2. Olah, M., V. Menon, N. Habib, M.F. Taga, Y. Ma, C.J. Yung, M. Cimpean, A. Khairallah, G. Coronas-Samano, R. Sankowski, D. Grun, A.A. Kroshilina, D. Dionne, R.A. Sarkis, G.R. Cosgrove, J. Helgager, J.A. Golden, P.B. Pennell, M. Prinz, J.P.G. Vonsattel, A.F. Teich, J.A. Schneider, D.A. Bennett, A. Regev, W. Elyaman, E.M. Bradshaw, and P.L. De Jager, Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer's disease. Nature Communications, 2020 Nov 30;11(1):6129 doi: 10.1038/s41467-020-19737-2.
  3. Zeljko Tomljanovic, Mitesh Patel, William Shin, Andrea Califano, Andrew F. Teich. ZCCHC17 is a master regulator of synaptic gene expression in Alzheimer's Disease. Bioinformatics, 2018 Feb 1;34(3):367-371.
  4. A. F. Teich, Sakurai M., Patel M., Holman C., Saeed F., Fiorito J., Arancio O. PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease. Journal of Alzheimer's Disease, 2016 9;52(1): 295-302.
  5. Teich AF, Patel M, Arancio O. A Reliable Way to Detect Endogenous Murine β-Amyloid. PLoSOne. (2013) 8(2):e55647.

For a complete list of publications, please visit PubMed.gov